Now I have sufficient calibration data. Let me produce the final consolidated review.

## Summary

DeepScientist presents an LLM-based multi-agent system for goal-oriented autonomous scientific discovery. It formalizes discovery as a Bayesian Optimization problem with a persistent Findings Memory, operating across three iterative stages (hypothesize, implement/verify, analyze/report). Evaluated on three frontier AI research tasks (Agent Failure Attribution, LLM Inference Acceleration, AI Text Detection), the system consumed ~20,000 GPU hours, generated ~5,000 ideas, implemented ~1,100, and produced methods that surpass human SOTA by 183.7%, 1.9%, and 7.9% respectively.

## Strengths

- **Scale of engineering effort is genuinely impressive.** Consuming ~20,000 GPU hours across three real AI research tasks, generating ~5,000 unique ideas, implementing ~1,100, and producing 5 full research papers is a substantial undertaking that goes well beyond typical AI Scientist demonstrations on synthetic or narrow-scope problems (Section 4.1, Section 4.3).

- **The discovered methods appear to be real scientific contributions, not trivial recombinations.** A2P's counterfactual reasoning framework for failure attribution, ACRA's stable-suffix pattern exploitation for speculative decoding, and the T-Detect/TDT/PA-TDT sequence for AI text detection all read as genuine methodological contributions with plausible rationales. The conceptual trajectory from T-Detect (robust t-statistics) to TDT (wavelet analysis) to PA-TDT (phase congruency) shows progressive deepening characteristic of real scientific discovery (Section 4.1).

- **The analysis of the discovery funnel is informative.** The finding that ~60% of failed trials stem from implementation errors rather than flawed hypotheses (Section 4.3) provides a concrete, actionable insight for the field. The t-SNE visualization of the conceptual search space (Figure 5) and the demonstration that the system builds on its own prior successes rather than random-walking are genuine contributions to understanding autonomous science.

## Weaknesses

### Major

**1. "Fully autonomous" claim is contradicted by unreported human supervision.** Section 4 states: "Three human experts supervise the process to verify outputs and filter out hallucinations." This is mentioned exactly once with no further quantification. Yet the abstract claims "fully autonomous scientific discovery" and the conclusion claims "end-to-end autonomy." Without knowing how many human interventions occurred, what fraction of outputs required filtering, or whether human feedback steered research directions, the reader cannot evaluate the autonomy claim. This is a structural issue: the paper's core identity as an "autonomous" system is undermined by the unquantified human involvement.

**2. No variance estimates on any experimental result.** All main results (Section 4.1) are reported as single numbers — e.g., 190.25→193.90 tokens/second (a 1.9% improvement) — with no error bars, confidence intervals, or multiple-run statistics. The 1.9% LLM inference improvement could easily lie within the noise of a single run. The only variance reported is in Table 3 (human evaluation), paradoxically making the subjective ratings more rigorously quantified than the objective performance metrics. Error estimates are needed for at least the LLM inference result, where the claimed improvement is marginal.

**3. The "two weeks vs. three years" comparison (Figure 1) conflates chronological time with research effort.** The left panel assembles a curated set of methods developed by different groups under different conditions (2019–2025) and plots their RAID AUROC scores as a "gradual progress curve." This is not a controlled experiment: the human methods were developed without 16 H800 GPUs and an automated implementation agent, and the timeline includes unrelated work, reviewing cycles, and community adoption. The abstract treats this as quantitative evidence of compression, which is not supported by the comparison design.

### Minor

**4. Bayesian Optimization terminology is inflated relative to the implementation.** The paper claims to "formally model" discovery as a BO problem with a "Bayesian surrogate model and acquisition function." In practice, the surrogate is an LLM prompted to output integer scores (0–100) for utility/quality/exploration, and the acquisition function is UCB applied to a linear combination with all weights set to 1. There is no Gaussian Process, no formal posterior distribution, and no proper uncertainty quantification over the value function (Section 3, Equation 1). The vocabulary suggests mathematical rigor not present in the implementation.

**5. Comparison against other AI Scientist systems (Table 2) is uninformative.** DeepScientist achieves a 60% simulated acceptance rate from DeepReviewer while every other system scores exactly 0%. The paper itself notes that "Publicly available papers may be curated," which largely neutralizes the comparison. The extreme 0% vs. 60% separation suggests the evaluation protocol is not calibrated to distinguish quality fairly across systems.

**6. Scaling analysis does not convincingly support the "near-linear" characterization (Figure 6).** With only 5 data points (1, 2, 4, 8, 16 GPUs) and the first two at 0 progress ideas, the "overall" curve (0, 0, 1, 4, 11) is being driven by task aggregation — individual task curves are essentially flat (0–2 progress ideas). Claiming a "near-linear relationship" (Section 4.3) is overstated relative to the data shown.

**7. Additional comparison methods in Figure 3 are shown but not discussed.** The bar charts include AgentTracer, DeepSeek-R1, Gemini-2.5-PRO, Claude-4-Sonnet, GPT-O5S-120B, but the text only describes the baseline and DeepScientist's method. The numerical data for these comparisons is not provided.

### Trivial

None.

## Nice-to-Haves

- **Error bars for the Agent Failure Attribution result**, while not strictly necessary given the large margin, would strengthen the paper.
- **Cross-benchmark validation** of the discovered methods (e.g., ACRA evaluated beyond MBPP) would support generalizability claims.
- **Reporting LLM API costs** alongside GPU-hour costs would give a more complete picture of the system's resource footprint.
- **More systematic analysis of why specific failures occurred** beyond the implementation-error finding (e.g., why 16 of the 21 progress findings did not result in papers).

## Removed Points

These points from the harsh critic review were removed as they fail the filtering criteria:

- "The paper overstates the prior literature's limitations" (subjective reading, not verifiably wrong)
- "Semiconductor and photovoltaic analogies are tangential" (style preference, not a substantive weakness)
- "The surrogate model scores are uncalibrated" (subsumed by BO terminology criticism, which is retained)
- "The baseline accuracy of 12.07% is low, needs context" (not a structural weakness; the relative improvement stands regardless)
- "ACRA evaluated only on MBPP; needs cross-benchmark validation" (moved to nice-to-have — beyond stated scope)
- "API costs not reported" (moved to nice-to-have — not central to claims)
- "No discussion of failure cases beyond implementation errors" (partially addressed in Section 4.3)
- "Random sampling baseline 'effectively zero' is not quantified" (presentation detail, not a core flaw)

## Novel Insights

None beyond the paper's own contributions. The reviews surface a tension the paper does not address: DeepScientist's most dramatic result (183.7% improvement) comes on a task where the human baseline is surprisingly weak (12–16% accuracy), while its most incremental result (1.9% improvement) comes on a heavily optimized task where the baseline is strong. The paper would benefit from explicitly calibrating which results signal genuine scientific breakthroughs and which represent incremental engineering wins under favorable conditions.

## Suggestions

1. **Quantify human supervision**: Report the number and nature of human interventions. Even better: run the system without human filtering on a subset to establish a baseline for autonomy.
2. **Add variance estimates**: Run at least the LLM inference acceleration experiment with 3–5 seeds to assess whether the 1.9% improvement is significant.
3. **Replace or honestly qualify the "two weeks vs. three years" comparison**: Either perform a controlled comparison (identical compute budget, same starting point) or clearly label Figure 1 as an illustrative timeline, not quantitative evidence of compression.
4. **Tone down the Bayesian Optimization framing**: Acknowledge that the surrogate is an LLM-based scorer and clarify how this differs from standard BO.
5. **Provide numerical data for the additional methods shown in Figure 3** and ensure they are discussed in the text.

## Score and Decision

### Calibration Report

**All anchors retrieved across rounds:**

| Path | Avg Human Score | Round | Itemized? | Comparison |
|------|----------------|-------|-----------|------------|
| /home/.../8QTpYC4smR.md | 1.00 | R1 | No | LLM survey paper (strong reject) — far weaker than DeepScientist |
| /home/.../5kMwiMnUip.md | 1.40 | R1 | No | Jailbreaking paper (strong reject) |
| /home/.../Uj0h13lVrR.md | 1.00 | R1 | No | GFlowNets paper (strong reject) |
| /home/.../nSDOkm0SKo.md | 1.00 | R1 | No | Financial markets paper (strong reject) |
| /home/.../IZiKBis0AA.md | 3.00 | R1 | No | Antibiotic drug design (reject) — less ambitious than DeepScientist |
| /home/.../t9U3LW7JVX.md | 3.00/6.00* | R1 | No | Automated Agentic Design — split reviews, avg pulled down |
| /home/.../FwjEZZ3j91.md | 3.00 | R1 | No | Symbolic regression (reject) |
| /home/.../CaNp8ALCRT.md | 3.00 | R1 | No | Drug discovery (reject) |
| /home/.../PHkUNcno9n.md | 4.67 | R1 | Yes | BALSA benchmark (reject) — less empirical than DeepScientist |
| /home/.../Ia17iAtr0P.md | 5.33 | R1 | No | Physics-constrained SR (reject) |
| /home/.../lWN2aGg8qJ.md | 4.00 | R1 | No | Chemistry BO (reject) |
| /home/.../TqzNI4v9DT.md | 4.25 | R1 | No | Symbolic regression benchmark (reject) |
| /home/.../aVfDrl7xDV.md | 6.25 | R1 | Yes | BOPRO (accept) — cleaner BO+LLM paper, similar score band |
| /home/.../OSmjkkF6Uy.md | 5.80 | R1 | No | FunBO (reject) |
| /home/.../womU9cEwcO.md | 6.67 | R1 | No | Autonomous agents (accept) |
| /home/.../IwhvaDrL39.md | 5.75 | R1 | Yes | Research Town (reject) — similar ambition, less concrete results |
| /home/.../m2nmp8P5in.md | 8.00 | R1 | Yes | LLM-SR (accept) — cleaner execution, smaller scope |
| /home/.../zMPHKOmQNb.md | 8.00 | R1 | No | Protein Discovery (accept) |
| /home/.../Q6a9W6kzv5.md | 8.00 | R1 | No | PhysBench (accept) |
| /home/.../vrBVFXwAmi.md | 8.00 | R1 | No | LLM4QPE (accept) |
| /home/.../X9OfMNNepI.md | 6.25 | R2 | Yes | Chemistry hypotheses (accept) — similar method strength |
| /home/.../6z4YKr0GK6.md | 6.00 | R2 | Yes | ScienceAgentBench (accept) — rigorous, less ambitious |
| /home/.../HAwZGLcye3.md | 6.40 | R2 | Yes | BioDiscoveryAgent (accept) — closest methodological match |
| /home/.../EyaH1wzmao.md | 6.33 | R2 | No | Ramanujan Library (accept) |
| /home/.../AUBvo4sxVL.md | 6.00 | R2 | No | MatExpert (accept) |
| /home/.../HBf6HFnpmH.md | 5.50 | R2 | No | Causal model scalability (reject) |

\* Average of 10, 8, 3, 3

**Bracket and narrowing:**

**Round 1 bracket:** 5.5–7.5 (Band 4). The paper is stronger than Band 3 papers (rejected at 3–5.33) but has more framing issues than clean Band 5 papers (8.0).

**Round 2 narrowing:** Comparing weighted items, DeepScientist's strengths (8.71–9.51) are comparable to BioDiscoveryAgent (6.39–10.34, accepted at 6.40) and notably stronger than Research Town's (~8.5, rejected at 5.75). DeepScientist's credible weaknesses (weights 0.06, −0.10, −0.30) are similar in count to BioDiscoveryAgent's (−0.20, −3.97, −0.10) but center on framing/evidence quality rather than incremental methodological concerns. ScienceAgentBench (6.00, accepted) had one negative-weight weakness (−0.72). Research Town (5.75, rejected) had one negative-weight weakness (−2.41) and weaker strengths. DeepScientist's strength weights are substantially higher than Research Town's, placing it above that rejection threshold. The presence of 3 credible weaknesses versus BioDiscoveryAgent's 3 positions it slightly below BioDiscoveryAgent's 6.40.

**Final score: 6.0** — The paper's genuine large-scale empirical contributions and the quality of discovered methods justify acceptance, but the overclaiming on autonomy, the misleading "two weeks vs. three years" comparison, and the absence of variance estimates (especially for the 1.9% result) prevent a higher score. These issues are fixable in revision.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>